Laboratorio Reig Jofre (RJF.MC)

Executive Summary

Laboratorio Reig Jofre is a Spanish generic pharmaceutical company founded in 1929, dedicated to making essential healthcare solutions universally accessible. With a mission to ensure treatments reach everyone regardless of location or socioeconomic status, the company focuses on producing high-quality generic drugs that improve global well-being. Listed on the Madrid Stock Exchange under the ticker RJF.MC, Reig Jofre has an estimated valuation of approximately $226 million and a portfolio of 10 commercial products. The company is well-positioned in the growing generic drug market, driven by increasing demand for affordable healthcare and patent expirations of branded drugs. Its long history and commitment to meaningful science provide a solid foundation for future growth, though the competitive landscape and pricing pressures remain challenges.

Upcoming Catalysts (preview)

• Q4 2026Launch of new generic products in pipeline70% success
• 2027Expansion into emerging markets via partnerships60% success
• TBDPotential regulatory approval for a high-value generic50% success